Sitagliptin Tablets
50mg · 100mg
Inhibits DPP-4 to enhance incretin hormones, improving glycaemic control in type 2 diabetes mellitus by increasing insulin secretion and decreasing glucagon in a glucose-dependent manner.
From$2.71/ tabletView
The medicines shown here belong to the Diabetes Management category and are used for managing Improve Glycaemic Control in Adult Patients with Type 2 Diabetes Mellitus as Triple Oral Therapy in Combination with A Sulphonylurea and Metformin. Products containing Sitagliptin feature in this group.
50mg · 100mg
Inhibits DPP-4 to enhance incretin hormones, improving glycaemic control in type 2 diabetes mellitus by increasing insulin secretion and decreasing glucagon in a glucose-dependent manner.
Review product labelling and speak with a healthcare professional before treatment decisions.